The Seventeenth International Conference on Endothelin (ET-17).

The Seventeenth International Conference on Endothelin (ET-17).
复制标题

第十七届国际内皮素会议(ET-17)。

DOI:
10.1139/cjpp-2022-0091
复制
发表时间:
2022
影响因子:
2.1
通讯作者:
Hyndman,KellyA
Hyndman,KellyA
中科院分区:
医学4区
文献类型:
--
作者:
Gumz,MichelleL;Hyndman,KellyA

文献摘要

参考文献

相似文献

第十七届内皮素(ET-17)国际会议于2021年10月4日至7日举行,由于SARS-CoV-2大流行,会议以虚拟方式举行。ET-17由美国生理学会赞助,为期4个半天,展示了与所有器官系统相关的令人兴奋的研究。自从Lancet的文章报道了成功的SONAR临床试验,内皮素受体A阻滞剂在糖尿病肾病中的应用,人们对使用内皮素受体拮抗剂治疗各种疾病重新产生了兴趣。从严格的临床前研究到最新的临床试验,ET-17充满了令人兴奋的科学,其中一些在这期特刊中报道。我们欢迎新的实验室参加会议,每个人都留下了这样的印象,即与ET相关的研究是一个充满活力的领域,正在取得非常重要的发现。
The Seventeenth International Conference on Endothelin (ET-17) was held during 4–7 October 2021 and because of the SARS-CoV-2 pandemic it was held virtually. Sponsored by the American Physiological Society, ET-17 was held over 4 half-days, with exciting studies related to all organ systems presented. Since theLancetarticle reporting the successful SONAR clinical trial with endothelin receptor A blockade in diabetic nephropathy, there has been renewed interest in the use of endothelin receptor antagonists in the treatment of a variety of diseases. From the rigorous preclinical studies to the latest clinical trials, ET-17 was full of exciting science, some of which is reported in this special issue. We welcomed new labs to the meeting and everyone left with the impression that ET-related research is a vibrant field with very significant discoveries being made.
第十四届国际内皮素会议 (ET-14),美国萨凡纳
DOI: 10.1016/j.lfs.2016.06.015
发表时间: 2016
期刊: Life sciences
影响因子: 6.1
作者:
D. Pollock;A. Gulati;A. Ergul
通讯作者: A. Ergul
DOI: 10.1016/j.kint.2019.05.007
发表时间: 2019-10-01
影响因子: 19.6
作者:
Ebefors, Kerstin;Wiener, Robert J.;Daehn, Ilse
通讯作者: Daehn, Ilse
内皮素 XVI。
DOI: 10.1139/cjpp-2020-0376
发表时间: 2020
影响因子: 2.1
作者:
B. Widyantoro;N. Emoto
通讯作者: N. Emoto